| scholarly article | Q13442814 |
| P50 | author | Didier Desmaële | Q76491341 |
| P2093 | author name string | Alain Tomas | |
| Nadia Guerra | |||
| Ming Wei | |||
| Anthony Kermagoret | |||
| Jean d'Angelo | |||
| Ahmed Mohsen | |||
| Philippe Collery | |||
| Gérard Bastian | |||
| François Santoni | |||
| Samantha Corre | |||
| P2860 | cites work | Dichlorotetra-mu-Isobutyratodirhenium(III): enhancement of cisplatin action and RBC-stabilizing properties. | Q50683177 |
| Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer. | Q53279443 | ||
| Initial activation status of the antioxidant response determines sensitivity to carboplatin/paclitaxel treatment of ovarian cancer | Q60565916 | ||
| Supplementation with selenium augments the functions of natural killer and lymphokine-activated killer cells | Q71541984 | ||
| fac-[Re(CO)3(H2O)3]+ nucleoside monophosphate adducts investigated in aqueous solution by multinuclear NMR spectroscopy | Q80344684 | ||
| Serum levels of selenium in patients with breast cancer before and after treatment of external beam radiotherapy | Q85160500 | ||
| Regulation of immune cell function and differentiation by the NKG2D receptor | Q24635093 | ||
| The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities | Q26827989 | ||
| Selenium cytotoxicity in cancer | Q26865042 | ||
| Post-protein-binding reactivity and modifications of the fac-[Re(CO)3]+ core | Q27676648 | ||
| NKG2D-DAP10 triggers human NK cell–mediated killing via a Syk-independent regulatory pathway | Q28203601 | ||
| Reactions of fac-[Re(CO)3(H2O)3]+ with nucleoside diphosphates and thiamine diphosphate in aqueous solution investigated by multinuclear NMR spectroscopy | Q31132163 | ||
| Binding interaction of [Re(H2O)3(CO)3]+ with the DNA fragment d(CpGpG). | Q31136201 | ||
| Novel library of selenocompounds as kinase modulators. | Q33973521 | ||
| 1,4-phenylenebis(methylene)selenocyanate, but not selenomethionine, inhibits androgen receptor and Akt signaling in human prostate cancer cells | Q34074062 | ||
| NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study | Q34132372 | ||
| Regulation of ligands for the NKG2D activating receptor | Q34321457 | ||
| Selenium: a key element that controls NF-kappa B activation and I kappa B alpha half life. | Q34377783 | ||
| Synthesis and evaluation of the anti-inflammatory properties of selenium-derivatives of celecoxib. | Q34417632 | ||
| The selenium metabolite methylselenol regulates the expression of ligands that trigger immune activation through the lymphocyte receptor NKG2D | Q34467682 | ||
| Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells | Q34474566 | ||
| Organometallic anticancer compounds | Q34476685 | ||
| Anticancer Properties of Novel Rhenium Pentylcarbanato Compounds against MDA-MB-468(HTB-132) Triple Node Negative Human Breast Cancer Cell Lines | Q34532317 | ||
| Magnetic resonance and fluorescence-protein imaging of the anti-angiogenic and anti-tumor efficacy of selenium in an orthotopic model of human colon cancer. | Q35084630 | ||
| Selenium in the Immune System | Q35121090 | ||
| Remarkable inhibition of mTOR signaling by the combination of rapamycin and 1,4-phenylenebis(methylene)selenocyanate in human prostate cancer cells | Q36098645 | ||
| Selenoproteins mediate T cell immunity through an antioxidant mechanism | Q36761847 | ||
| Selenium and inflammation: underlying anti-inflammatory mechanisms | Q37471628 | ||
| Selenium as a chemoprotective anti-cancer agent: reality or wishful thinking? | Q37766853 | ||
| Kinase regulation by sulfur and selenium containing compounds. | Q37852056 | ||
| Bimodal actions of selenium essential for antioxidant and toxic pro-oxidant activities: the selenium paradox (Review). | Q37952530 | ||
| Selenium compounds, apoptosis and other types of cell death: an overview for cancer therapy | Q38040788 | ||
| Is selenium a potential treatment for cancer metastasis? | Q38097279 | ||
| Inflammation and cancer stem cells. | Q38128635 | ||
| Mapping oxidative changes in breast cancer: understanding the basic to reach the clinics | Q38193412 | ||
| Underestimated potential of organometallic rhenium complexes as anticancer agents | Q38241256 | ||
| Uptake and efflux of rhenium in cells exposed to rhenium diseleno-ether and tissue distribution of rhenium and selenium after rhenium diseleno-ether treatment in mice | Q39009126 | ||
| Probing the selective antitumor activity of 22-oxo-26-selenocyanocholestane derivatives | Q39028048 | ||
| Preparation of a novel organoselenium compound and its anticancer effects on cervical cancer cell line HeLa | Q39225585 | ||
| Rhenium(I) tricarbonyl complexes of salicylaldehyde semicarbazones: synthesis, crystal structures and cytotoxicity | Q39241633 | ||
| Combination of three metals for the treatment of cancer: gallium, rhenium and platinum. 1. Determination of the optimal schedule of treatment. | Q39321034 | ||
| Importance of NKG2D-NKG2D ligands interaction for cytolytic activity of natural killer cell | Q39345189 | ||
| The quinoline imidoselenocarbamate EI201 blocks the AKT/mTOR pathway and targets cancer stem cells leading to a strong antitumor activity. | Q39372766 | ||
| Sulfur and selenium derivatives of quinazoline and pyrido[2,3-d]pyrimidine: synthesis and study of their potential cytotoxic activity in vitro. | Q39439301 | ||
| Molecular subtype is determinant on inflammatory status and immunological profile from invasive breast cancer patients. | Q39614413 | ||
| Synthesis and antiproliferative activity of novel symmetrical alkylthio- and alkylseleno-imidocarbamates. | Q39626275 | ||
| Selenium‐ and Tellurium‐Containing Multifunctional Redox Agents as Biochemical Redox Modulators with Selective Cytotoxicity | Q39672807 | ||
| Novel dinuclear platinum(II) complexes targets NFkappaB signaling pathway to induce apoptosis and inhibit metabolism of MCF-7 breast cancer cells. | Q39752972 | ||
| Synthesis, characterization, in vivo antitumor properties of the cluster rhenium compound with GABA ligands and its synergism with cisplatin | Q39831849 | ||
| Selenium attenuates pro-inflammatory gene expression in macrophages | Q39982136 | ||
| Selenium and immune function. | Q41748617 | ||
| Selenium and the immune response: 2. Enhancement of murine cytotoxic T-lymphocyte and natural killer cell cytotoxicity in vivo | Q42494628 | ||
| A less stressful alternative to oral gavage for pharmacological and toxicological studies in mice | Q42578076 | ||
| Selenium and the immune response: 1. Modulation of alloreactive human lymphocyte functions in vitro | Q44240964 | ||
| In vivo recognition of cyclopentadienyltricarbonylrhenium (CpTR) derivatives | Q44439661 | ||
| Head-to-head (HH) and head-to-tail (HT) conformers of cis-bis guanine ligands bound to the [Re(CO)3]+ core | Q44797930 | ||
| Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy. | Q45906140 | ||
| Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis | Q46316695 | ||
| Guanine and plasmid DNA binding of mono- and trinuclear fac-[Re(CO)3]+ complexes with amino acid ligands | Q46549866 | ||
| Selenium suppresses the activation of transcription factor NF-kappa B and IRF3 induced by TLR3 or TLR4 agonists | Q46750096 | ||
| SOD3 acts as a tumor suppressor in PC-3 prostate cancer cells via hydrogen peroxide accumulation | Q46880445 | ||
| An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status | Q47303472 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P921 | main subject | rhenium | Q737 |
| P304 | page(s) | 848-860 | |
| P577 | publication date | 2015-06-26 | |
| P1433 | published in | Investigational New Drugs | Q2312231 |
| P1476 | title | Antitumor activity of a rhenium (I)-diselenoether complex in experimental models of human breast cancer | |
| P478 | volume | 33 |
| Q41326765 | Crystal structure of a second polymorph of tricarbon-yl(N-methyl-pyridine-2-carboxamide-κ2N1,O)(thio-cyanato-κN)rhenium(I). |
| Q92093269 | In Vivo Anticancer Activity of a Rhenium(I) Tricarbonyl Complex |
| Q50972159 | Photophysical properties of rhenium(i) complexes and photosensitized generation of singlet oxygen. |
| Q90512736 | Rhenium-based complexes and in vivo testing: A brief history |
| Q55034518 | The Effects of Synthesized Rhenium Acetylsalicylate Compounds on Human Astrocytoma Cell Lines. |
Search more.